Gregory Bailey, a director at $BHVN, bought 400,000 shares of the company on 11-13-2025 for an estimated $3,000,000. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 24.7%. Following this trade, they now own 2,020,071 shares of this class of $BHVN stock.
$BHVN Insider Trading Activity
$BHVN insiders have traded $BHVN stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BHVN stock by insiders over the last 6 months:
- JOHN W CHILDS purchased 3,333,333 shares for an estimated $24,999,997
- VLAD CORIC (Chief Executive Officer) has made 2 purchases buying 666,666 shares for an estimated $4,999,995 and 0 sales.
- GREGORY BAILEY purchased 400,000 shares for an estimated $3,000,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BHVN Hedge Fund Activity
We have seen 136 institutional investors add shares of $BHVN stock to their portfolio, and 142 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC removed 6,374,407 shares (-68.9%) from their portfolio in Q3 2025, for an estimated $95,679,849
- FARALLON CAPITAL MANAGEMENT LLC removed 4,813,167 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $67,913,786
- JANUS HENDERSON GROUP PLC added 1,718,585 shares (+34.0%) to their portfolio in Q3 2025, for an estimated $25,795,960
- VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 1,285,482 shares (-89.3%) from their portfolio in Q3 2025, for an estimated $19,295,084
- JPMORGAN CHASE & CO removed 1,236,587 shares (-48.1%) from their portfolio in Q3 2025, for an estimated $18,561,170
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,161,624 shares (-36.6%) from their portfolio in Q3 2025, for an estimated $17,435,976
- INFINITUM ASSET MANAGEMENT, LLC added 1,150,000 shares (+209.1%) to their portfolio in Q3 2025, for an estimated $17,261,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BHVN Analyst Ratings
Wall Street analysts have issued reports on $BHVN in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 11/13/2025
- BTIG issued a "Buy" rating on 11/06/2025
- TD Cowen issued a "Buy" rating on 11/05/2025
- UBS issued a "Buy" rating on 09/16/2025
- Raymond James issued a "Strong Buy" rating on 09/03/2025
- Morgan Stanley issued a "Overweight" rating on 08/12/2025
- Leerink Partners issued a "Outperform" rating on 08/12/2025
To track analyst ratings and price targets for $BHVN, check out Quiver Quantitative's $BHVN forecast page.
$BHVN Price Targets
Multiple analysts have issued price targets for $BHVN recently. We have seen 13 analysts offer price targets for $BHVN in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Samantha Semenkow from Citigroup set a target price of $14.0 on 11/13/2025
- Thomas Shrader from BTIG set a target price of $16.0 on 11/06/2025
- Leonid Timashev from RBC Capital set a target price of $9.0 on 11/06/2025
- William Pickering from Bernstein set a target price of $9.0 on 11/06/2025
- Tyler Van Buren from TD Cowen set a target price of $15.0 on 11/05/2025
- Ashwani Verma from UBS set a target price of $26.0 on 09/16/2025
- Chris Raymond from Raymond James set a target price of $75.0 on 09/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
